Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTRMR.L Regulatory News (TRMR)

  • There is currently no data for TRMR

Director Dealing and TVR

3 Oct 2017 16:55

RNS Number : 6074S
Taptica International Ltd
03 October 2017
 

Taptica International Ltd

("Taptica" or the "Company")

 

Director Dealing and Total Voting Rights

 

Taptica (AIM: TAP), a global end-to-end mobile advertising platform, announces that, on 11 September 2017 (the "Grant Date"), it approved the issue and allotment of 1,617 ordinary shares of NIS 0.01 each in the capital of the Company ("Ordinary Shares") to Ronni Zehavi, a Non-Executive Director of the Company. The new Ordinary Shares were issued at £3.87 per Ordinary Share, representing the average closing price of an Ordinary Share for the 30 days prior to the Grant Date, and were issued to satisfy Ronni Zehavi's pre-approved director fees for the three months ended 20 August 2017. Application has been made to the London Stock Exchange for Admission of 1,617 New Ordinary Shares to trading on AIM ("Admission"). It is expected that Admission will take place on 6 October2017. The New Ordinary Shares will rank pari passu with the Company's existing issued ordinary shares.

 Total Voting Rights

 

For the purposes of the Financial Conduct Authority's Disclosure and Transparency Rules, the Company's issued share capital consists of 61,800,840 ordinary shares with a nominal value of 0.01 pence each ('Ordinary Shares'), along with 8,088,337 shares reclassified as dormant shares under the Israeli Companies Law (without any rights attached thereon). Therefore the total number of shares with voting rights will be 61,800,840. The Company does not hold any Ordinary Shares in Treasury. 

The above figure of 61,800,840 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

For further details:

 

Taptica

Hagai Tal, Chief Executive Officer

 

finnCap (Nomad and Joint Broker)

Jonny Franklin Adams, James Thompson

Tim Redfern, Richard Chambers

 

Berenberg (Joint Broker)

Chris Bowman, Mark Whitmore

 

Luther Pendragon (Financial PR Adviser)

Harry Chathli, Claire Norbury

 

+972 3 545 3900

 

 

+44 20 7220 0500

 

 

+44 20 3207 7800

 

 

+44 20 7618 9100

 

About Taptica

 

Taptica is a global end-to-end mobile advertising platform that helps the world's top brands reach their most valuable users with the widest range of traffic sources available today, including social. Its proprietary technology leverages big data and, combined with state-of-the-art machine learning, enables quality media targeting at scale. Taptica creates a single arena in which brands can scale and engage more relevantly with mobile audiences, staying ahead of the competition. It works with more than 600 advertisers including Amazon, Disney, Facebook, Twitter, OpenTable, Expedia, Lyft and Zynga. Taptica is headquartered in Israel with offices in San Francisco, New York, Boston, Beijing, Seoul and London. Taptica is traded on the London Stock Exchange (AIM: TAP).

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCMJBATMBAMBMR
Date   Source Headline
9th Jan 20247:01 amRNSShare buyback-transaction in own shares
9th Jan 20247:00 amRNSChange of Name
5th Jan 20247:00 amRNSShare buyback-transaction in own shares
4th Jan 20247:00 amRNSShare buyback-transaction in own shares
3rd Jan 20247:00 amRNSShare buyback-transaction in own shares
2nd Jan 20248:54 amRNSTotal Voting Rights
28th Dec 20237:00 amRNSShare buyback-transaction in own shares
27th Dec 202312:22 pmRNSResults of Annual General Meeting
27th Dec 202311:28 amRNSDirector Dealings
21st Dec 20238:49 amRNSShare Buyback - Transaction in Own Shares
18th Dec 20232:00 pmRNS$20 Million Share Repurchase Programme
15th Dec 20232:00 pmRNSPartnership with Taiv to Expand CTV OOH Offering
14th Dec 202310:55 amRNSDirector Dealings
6th Dec 202310:40 amRNSDirector Dealings
1st Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20231:30 pmRNSTremor to Present at Raymond James Conference
27th Nov 202310:58 amRNSDirector Dealings
22nd Nov 202310:30 amRNSNotice of Annual General Meeting
22nd Nov 20237:00 amRNSQ3 & 9-Month 2023 Results
21st Nov 20232:00 pmRNSLaunch in UK & Expansion in US
21st Nov 202311:30 amRNSDirector Dealings
17th Nov 20231:20 pmRNSDirector Dealings
9th Nov 20237:00 amRNSQ3 2023 Results Conference Call Details
18th Oct 20237:00 amRNSDirector Dealings
4th Oct 20232:00 pmRNSEnhanced Leadership Team Bolsters CTV Expertise
2nd Oct 20238:54 amRNSTotal Voting Rights
26th Sep 20232:01 pmRNSDirector Dealings
14th Sep 20237:00 amRNSMotion with Israeli Court for Share Repurchase
4th Sep 20234:30 pmRNSResponse to Press Speculation
1st Sep 20231:13 pmRNSTotal Voting Rights
24th Aug 20232:00 pmRNSCross-Platform Planner Boosted, CTV Revenue Climbs
21st Aug 20234:30 pmRNSDirector Dealings
17th Aug 20237:00 amRNSQ2 and H1 2023 Results
8th Aug 20237:00 amRNSQ2 and H1 2023 Results Conference Call Details
1st Aug 20238:38 amRNSTotal Voting Rights
28th Jul 20238:45 amRNSDirector Dealings
18th Jul 20239:06 amRNSDirector Dealings
13th Jul 20237:00 amRNSBlock Listing Six Monthly Return
3rd Jul 20234:06 pmRNSTotal Voting Rights
3rd Jul 202312:08 pmRNSDirector Dealings
30th Jun 20231:53 pmRNSPosting of Annual Report and Accounts
12th Jun 202311:00 amRNSTremor International Group Rebrands as Nexxen
2nd Jun 202310:24 amRNSTotal Voting Rights
30th May 20237:00 amRNSQ1 2023 Results
18th May 20237:00 amRNSQ1 2023 Results Conference Call Details
9th May 20232:00 pmRNSTremor to Offer Green CTV Products with Scope3
2nd May 20232:00 pmRNSTremor's Unruly SSP Partners with TCL FFALCON
2nd May 20237:00 amRNSTotal Voting Rights
26th Apr 20232:00 pmRNSTremor Launches Cross-Platform Planner
19th Apr 20232:15 pmRNSDirector Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.